'Definitive Data': Continuing ACE/ARB Tx Safe in COVID-19

(MedPage Today) -- Stopping an ACE inhibitor or angiotensin receptor blocker (ARB) at admission for COVID-19 doesn't help outcomes, even for high-risk groups, the BRACE CORONA randomized trial showed.
Continuing these drugs for patients on them...